These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 747820)

  • 1. Mitogenic and protective activity associated with a lipopolysaccharide from Coxiella burnetii.
    Paquet A; Rael ED; Klassen D; Martinez I; Baca OG
    Can J Microbiol; 1978 Dec; 24(12):1616-8. PubMed ID: 747820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of biological activities and mitogenic effect of extracts from Haemophilus influenzae type a.
    Raichvarg D; Guenounou M; Brossard C; Agneray J; Alouf JE
    Med Microbiol Immunol; 1980; 168(3):201-10. PubMed ID: 6967559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterization of the endotoxins from Coxiella burnetii strain Priscilla in relation to their bioactivities.
    Toman R; Garidel P; Andrä J; Slaba K; Hussein A; Koch MH; Brandenburg K
    BMC Biochem; 2004 Jan; 5():1. PubMed ID: 14715092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the biological responses induced by lipopolysaccharide and endotoxin of Treponema hyodysenteriae and Treponema innocens.
    Greer JM; Wannemuehler MJ
    Infect Immun; 1989 Mar; 57(3):717-23. PubMed ID: 2917784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some biological properties of an endotoxic lipopolysaccharide from the typhus group rickettsiae.
    Schramek S; Brezina R; Kazár J
    Acta Virol; 1977 Sep; 21(5):439-41. PubMed ID: 22240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity.
    Hackstadt T; Peacock MG; Hitchcock PJ; Cole RL
    Infect Immun; 1985 May; 48(2):359-65. PubMed ID: 3988339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic structure of Coxiella burnetii. A comparison of lipopolysaccharide and protein antigens as vaccines against Q fever.
    Williams JC; Hoover TA; Waag DM; Banerjee-Bhatnagar N; Bolt CR; Scott GH
    Ann N Y Acad Sci; 1990; 590():370-80. PubMed ID: 2378463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxicosis induced by Coxiella burnetii lipopolysaccharide stimulates a ribosomal protein S6 kinase: some properties of the partially purified enzyme.
    Picking WD; Hackstadt T; Paretsky D
    Infect Immun; 1989 Dec; 57(12):3683-8. PubMed ID: 2807543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of in vitro lymphocyte proliferation in C57BL/10 ScN mice vaccinated with phase I Coxiella burnetii.
    Damrow TA; Williams JC; Waag DM
    Infect Immun; 1985 Jan; 47(1):149-56. PubMed ID: 3965392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of the slime and endotoxin of the periodontopathic organism Eikenella corrodens.
    Behling UH; Pham PH; Nowotny A
    Infect Immun; 1979 Nov; 26(2):580-4. PubMed ID: 161911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological properties of the lipopolysaccharide-protein complex of Coxiella burnetii.
    Kazár J; Schramek S; Brezina R
    Acta Virol; 1978 Jul; 22(4):309-15. PubMed ID: 29470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenic response of mouse spleen cells and gelation of limulus lysate by lipopolysaccharide of Yersinia pestis and evidence for neutralization of lipopolysaccharide by polymyxin B.
    Butler T; Möller G
    Infect Immun; 1977 Nov; 18(2):400-4. PubMed ID: 200563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by Coxiella burnetii of ascites tumour formation in mice.
    Kazár J; Schramek S
    Acta Virol; 1979 May; 23(3):267-70. PubMed ID: 41443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coxiella burnetii Lipopolysaccharide: What Do We Know?
    Abnave P; Muracciole X; Ghigo E
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of lipopolysaccharides from oral Selenomonas.
    Hofstad T; Naess V; Skaug N
    Scand J Dent Res; 1986 Dec; 94(6):515-20. PubMed ID: 3468599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host--implications for post Q fever infection fatigue syndrome and other chronic sequelae.
    Marmion BP; Sukocheva O; Storm PA; Lockhart M; Turra M; Kok T; Ayres J; Routledge H; Graves S
    QJM; 2009 Oct; 102(10):673-84. PubMed ID: 19556396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii.
    Vishwanath S; Hackstadt T
    Infect Immun; 1988 Jan; 56(1):40-4. PubMed ID: 3335408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activities of the lipopolysaccharide and lipid A from Acinetobacter calcoaceticus.
    Brade H; Galanos C
    J Med Microbiol; 1983 May; 16(2):211-4. PubMed ID: 6842571
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4.
    Honstettre A; Ghigo E; Moynault A; Capo C; Toman R; Akira S; Takeuchi O; Lepidi H; Raoult D; Mege JL
    J Immunol; 2004 Mar; 172(6):3695-703. PubMed ID: 15004173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens.
    Izzo AA; Marmion BP; Hackstadt T
    Clin Exp Immunol; 1991 Jul; 85(1):98-108. PubMed ID: 2070564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.